Earnings Growth ConcernsAnalysts consider the company's growth target to reach the new midpoint of earnings growth, which requires an inflection from 2.5% to 12%, to be quite aggressive and unlikely.
Financial Performance4Q23 results showed improved performance but with earnings before interest, taxes, depreciation, and amortization (EBITDA) ending 26% lower than the midpoint of the original guide.
Regulatory ImpactThe Centers for Medicare & Medicaid Services (CMS) is expected to implement rate cuts that could eliminate any significant forward rate increase and earnings growth for an extended period.